These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 8672535

  • 61. N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity.
    John H, Maronde E, Forssmann WG, Meyer M, Adermann K.
    Eur J Med Res; 2008 Feb 25; 13(2):73-8. PubMed ID: 18424366
    [Abstract] [Full Text] [Related]

  • 62. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
    Waeber G, Thompson N, Waeber B, Brunner HR, Nicod P, Grouzmann E.
    Endocrinology; 1993 Sep 25; 133(3):1061-7. PubMed ID: 8396008
    [Abstract] [Full Text] [Related]

  • 63. Stimulation of rat parietal cell function by histamine and GLP-1-(7-36) amide is mediated by Gs alpha.
    Schmidtler J, Dehne K, Offermanns S, Rosenthal W, Classen M, Schepp W.
    Am J Physiol; 1994 May 25; 266(5 Pt 1):G775-82. PubMed ID: 8203524
    [Abstract] [Full Text] [Related]

  • 64. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD, Gault VA, Irwin N, Mooney MH, Bailey CJ, Harriott P, Greer B, Flatt PR, O'Harte FP.
    Biol Chem; 2003 Dec 25; 384(12):1543-51. PubMed ID: 14719796
    [Abstract] [Full Text] [Related]

  • 65. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.
    Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE.
    Endocrinology; 1993 Jul 25; 133(1):57-62. PubMed ID: 8391428
    [Abstract] [Full Text] [Related]

  • 66. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
    Kawai K, Suzuki S, Ohashi S, Mukai H, Ohmori H, Murayama Y, Yamashita K.
    Endocrinology; 1989 Apr 25; 124(4):1768-73. PubMed ID: 2564338
    [Abstract] [Full Text] [Related]

  • 67. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
    Delmeire D, Flamez D, Moens K, Hinke SA, Van Schravendijk C, Pipeleers D, Schuit F.
    Biochem Pharmacol; 2004 Jul 01; 68(1):33-9. PubMed ID: 15183115
    [Abstract] [Full Text] [Related]

  • 68. Glucagon-like peptide-I analogs: effects on insulin secretion and adenosine 3',5'-monophosphate formation.
    Gefel D, Hendrick GK, Mojsov S, Habener J, Weir GC.
    Endocrinology; 1990 Apr 01; 126(4):2164-8. PubMed ID: 2156683
    [Abstract] [Full Text] [Related]

  • 69. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA, Siemsglüss J, Orskov C, Holst JJ.
    Z Gastroenterol; 1996 Mar 01; 34(3):159-66. PubMed ID: 8650968
    [Abstract] [Full Text] [Related]

  • 70. Glucagon-like peptide 1: a potent glycogenic hormone.
    Valverde I, Morales M, Clemente F, López-Delgado MI, Delgado E, Perea A, Villanueva-Peñacarrillo ML.
    FEBS Lett; 1994 Aug 01; 349(2):313-6. PubMed ID: 8050588
    [Abstract] [Full Text] [Related]

  • 71. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA.
    Diabetologia; 2002 Oct 01; 45(10):1410-5. PubMed ID: 12378382
    [Abstract] [Full Text] [Related]

  • 72. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.
    González N, Acitores A, Sancho V, Valverde I, Villanueva-Peñacarrillo ML.
    Regul Pept; 2005 Mar 30; 126(3):203-11. PubMed ID: 15664668
    [Abstract] [Full Text] [Related]

  • 73. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
    Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA.
    J Clin Endocrinol Metab; 1996 Jan 30; 81(1):327-32. PubMed ID: 8550773
    [Abstract] [Full Text] [Related]

  • 74. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, Schmiegel WH.
    Am J Physiol; 1997 Nov 30; 273(5):E981-8. PubMed ID: 9374685
    [Abstract] [Full Text] [Related]

  • 75. Absence of insulinotropic glucagon-like peptide-I(7-37) receptors on isolated rat liver hepatocytes.
    Blackmore PF, Mojsov S, Exton JH, Habener JF.
    FEBS Lett; 1991 May 20; 283(1):7-10. PubMed ID: 1645298
    [Abstract] [Full Text] [Related]

  • 76. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
    Wang L, Guo F, Wei S, Zhao R.
    Peptides; 2011 Jun 20; 32(6):1313-9. PubMed ID: 21453734
    [Abstract] [Full Text] [Related]

  • 77. Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle.
    Villanueva-Peñacarrillo ML, Alcántara AI, Clemente F, Delgado E, Valverde I.
    Diabetologia; 1994 Nov 20; 37(11):1163-6. PubMed ID: 7867889
    [Abstract] [Full Text] [Related]

  • 78. The cGMP-inhibitable phosphodiesterase modulates glucose transport activation by insulin.
    Eriksson JW, Wesslau C, Smith U.
    Biochim Biophys Acta; 1994 Jan 19; 1189(2):163-7. PubMed ID: 8292620
    [Abstract] [Full Text] [Related]

  • 79. Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release.
    Gromada J, Rorsman P, Dissing S, Wulff BS.
    FEBS Lett; 1995 Oct 09; 373(2):182-6. PubMed ID: 7589461
    [Abstract] [Full Text] [Related]

  • 80. Dexamethasone pretreatment of rat insulinoma cells decreases binding of glucagon-like peptide-1(7-36)amide.
    Richter G, Göke R, Göke B, Arnold R.
    J Endocrinol; 1990 Sep 09; 126(3):445-50. PubMed ID: 2170555
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.